The Next Decade of Cell and Gene Therapies
May 7, 2025
Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.
5 min read
Business & Trends
FDA to Phase Out Animal Testing
By Rob Coker
April 11, 2025
FDA to phase out mandatory animal testing with human-relevant methods for drug development
2 min read
Partnerships To Be Precise
By Elizabeth Hickman, Dave Miller
April 11, 2025
In the ever volatile, highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.
3 min read
Trump Speech Suggests Pharma Tariffs Incoming
By Stephanie Vine
April 9, 2025
US President threatens “major tariff” on pharmaceuticals.
2 min read
Sitting Down With… The Past: Kowid Ho
April 9, 2025
We dive into the archive of 2022 for insight and inspiration – this time with Kowid Ho
3 min read
The Blood Cancer Success Story: Part 1
By Stephanie Vine
April 9, 2025
Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society; because there are some goals you can only accomplish in a not-for-profit environment.
7 min read
Is the FDA About to Break?
By Stephanie Vine
April 8, 2025
Job cuts at the FDA spark concern, with Robert Califf saying the agency as we know it is “finished.”
3 min read
Predictions for Pharma’s Future
April 8, 2025
We asked experts about their views of the future of pharma. Process digitization, data, and sustainability are key themes.
4 min read
The Economics of Biosimilars
By Stephanie Vine
April 4, 2025
We ask James Chambers from Tufts Medical Center about the challenges faced by biosimilars in the US
7 min read
Sitting Down With… The Past: Peter Marks
April 4, 2025
We dive into the archive of 2021 for insight and inspiration – this time with Peter Marks
3 min read
